Aneurysms of the posterior cerebral artery: classification and endovascular treatment

EF Ciceri, RP Klucznik, RG Grossman… - American journal …, 2001 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: We present a retrospective review of our experience in
the endovascular treatment of posterior cerebral artery (PCA) aneurysms. We detail the …

Treatment of intracranial aneurysms using the pipeline flex embolization device with shield technology: angiographic and safety outcomes at 1-year follow-up

…, SM Lamin, KG Lagios, T Liebig, EF Ciceri… - Journal of …, 2019 - jnis.bmj.com
Purpose The Pipeline Embolization Device (PED) is a routine first-line treatment option for
intracranial aneurysms (IAs). The Pipeline Flex Embolization Device with Shield Technology (…

Periprocedural outcomes and early safety with the use of the Pipeline Flex Embolization Device with Shield Technology for unruptured intracranial aneurysms …

…, SM Lamin, KG Lagios, T Liebig, EF Ciceri… - Journal of …, 2017 - jnis.bmj.com
Background and purpose The Pipeline Embolization Device (PED) has become a routine
first-line option for treatment of intracranial aneurysms (IAs). We assessed the early safety and …

Angiographically proven cervical venous engorgement: a possible concurrent cause in the pathophysiology of Hirayama's myelopathy

EF Ciceri, L Chiapparini, A Erbetta, L Longhi… - Neurological …, 2010 - Springer
The objective of this study is to discuss the possible role of cervical posterior epidural
plexus engorgement during cervical flexion in the pathogenesis of Hirayama myelopathy. In …

Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot …

…, MR Carriero, M Castori, EF Ciceri… - The Lancet …, 2023 - thelancet.com
Background Observations in people with cerebral cavernous malformations, and in preclinical
models of this disorder, suggest that the β-blocker propranolol might reduce the risk of …

Plasma lipid profiling contributes to untangle the complexity of moyamoya arteriopathy

…, IG Vetrano, F Acerbi, P Ferroli, EF Ciceri… - International Journal of …, 2021 - mdpi.com
… Angiogenic and inflammatory protein levels were measured by ELISA and a complete
lipidomic analysis was performed on plasma by mass spectrometry. ELISA showed a significant …

Vascular remodeling in moyamoya angiopathy: from peripheral blood mononuclear cells to endothelial cells

…, G Faragò, A Gioppo, EF Ciceri, F Acerbi… - International Journal of …, 2020 - mdpi.com
The pathophysiological mechanisms of Moyamoya angiopathy (MA), which is a rare
cerebrovascular condition characterized by recurrent ischemic/hemorrhagic strokes, are still largely …

[HTML][HTML] Paediatric stroke: review of the literature and possible treatment options, including endovascular approach

EF Ciceri, V Cuccarini, L Chiapparini… - Stroke research and …, 2011 - hindawi.com
Stroke is among the top 10 causes of death in childhood. More than half of the surviving
children have long-term neurological sequelae. Ischemic stroke (IS) includes arterial ischemic …

Characteristics of moyamoya disease in the older population: is it possible to define a typical presentation and optimal therapeutical management?

…, I Canavero, F Restelli, G Raccuia, EF Ciceri… - Journal of Clinical …, 2021 - mdpi.com
Whereas several studies have been so far presented about the surgical outcomes in terms
of mortality and perioperative complications for elderly patients submitted to neurosurgical …

Preoperative Embolization of Carotid Chemodectoma: A Technical Challenge that can be Customized According to Angioarchitecture: Illustrative Cases

…, C Berardi, B Pollo, EF Ciceri - The …, 2013 - journals.sagepub.com
Preoperative embolization of carotid paraganglioma is increasingly used to reduce the risk
of surgical bleeding obtaining a more precise and extensive tumor resection. Currently the …